| | A 52-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthma . . . |
Completed |
30 Mar 2021 |
| | A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study comparing GSK3196165 with placebo and with tofacitinib, in combination with methotrexate in participants with moder . . . |
Ongoing |
14 Aug 2020 |
| | A 52-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis . . . |
Pending |
10 May 2019 |
| | A 6-Month Safety, Efficacy, and Pharmacokinetic Trial of Delamanid in Pediatric Patients with Multi-Drug Resistant Tuberculosis . . . |
Completed |
09 Oct 2020 |
| | A 96-week, two-arm, randomized, single-masked, multi-center, phase III study assessing the efficacy and safety of brolucizumab 6 mg compared to panretinal photocoagulation laser in patients with proli . . . |
Pending |
21 May 2021 |
| | A cohort study to assess the burden of dengue illness in household members from selected communities in Southeast Asia and Latin America. . . . |
Completed |
28 Aug 2019 |
| | A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension . . . |
Ongoing |
30 Dec 2020 |
| | A controlled Phase 2/3 study of adjuvanted recombinant SARS-CoV-2 trimeric S-protein vaccine (SCB-2019) for the prevention of COVID-19 . . . |
Ongoing |
09 Feb 2021 |
| | A Double blind, Randomized, Placebo controlled, Single dose, Dose ascending Phase I Study to Evaluate the Safety, Tolerability and Pharmacodynamics (PD) of Niclosamide injectable (DWRX2003) following . . . |
Ongoing |
05 Oct 2020 |
| | A double-blind randomized controlled trial on the efficacy and safety of metformin as an adjunct to lymecycline and topical adapalene plus benzoyl peroxide gel in the treatment of moderate to severe a . . . |
Completed |
30 Nov -0001 |
| | A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Pregabalin As Adjunctive Therapy In Children 1 month through < 4 Years of Age with Partial Onset . . . |
Completed |
17 Jul 2019 |
| | A multi-center, double-blinded and open-label extension study to evaluate the efficacy and safety of ligelizumab as retreatment, self-administered therapy and monotherapy in Chronic Spontaneous Urtica . . . |
Ongoing |
21 May 2021 |
| | A Multi-center, Randomized, Active-controlled, Parallel-group, Open-label and Phase II Study to Evaluate Immunogenicity and Safety of LBVD (fully liquid hexavalent vaccine; Adsorbed Diphtheria-Tetanus . . . |
Ongoing |
14 Aug 2020 |
| | A multi-center, randomized, double-blind, active and placebo controlled study to investigate the efficacy and safety of ligelizumab (QGE031) in the treatment of Chronic spontaneous Urticaria (CSU) in . . . |
Ongoing |
30 Mar 2021 |
| | A multi-center, randomized, double-blind, placebo-controlled Phase 2/3 clinical trial to evaluate the safety and efficacy of pyronaridine-artesunate (Artecom®) in COVID-19 patients . . . |
Ongoing |
30 Mar 2021 |
| | A multicenter, double-blind, randomized withdrawal extension study of subcutaneous secukinumab to demonstrate long-term efficacy, safety and tolerability in subjects with moderate to severe hidradenit . . . |
Ongoing |
21 May 2021 |
| | A Multicenter, Open-label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab T . . . |
Ongoing |
18 Jun 2021 |
| | A multicenter, openlabel, follow-up study to assess the longterm use of Lacosamide (flexible dose from 200 to 600 mg/day) used as monotherapy in subjects who completed SP0994 and received Lacosamide m . . . |
Completed |
23 Sep 2020 |
| | A multicenter, randomized, 52-week, double-blind, parallel group, active controlled study to compare the efficacy and safety of QVM149 with QMF149 in patients with asthma . . . |
Completed |
23 Apr 2020 |
| | A multicenter, randomized, double-blind, active-controlled, 2 week treatment, parallel-group study to assess the efficacy and safety of indacaterol acetate delivered via the Concept1 inhalation device . . . |
Completed |
30 Mar 2021 |
| | A multicenter, randomized, double-blind, active-controlled, parallel-group phase 3 study to evaluate the efficacy and safety of LCZ696 compared to ramipril on morbidity and mortality in high risk pat . . . |
Ongoing |
30 Mar 2021 |
| | A Multicenter, Randomized, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab 100 mg in Patients with Moderate to Very S . . . |
Ongoing |
09 Jun 2021 |
| | A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patien . . . |
Completed |
19 Feb 2020 |
| | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial of MW33 Injection to Evaluate the Efficacy and Safety in Patients with Mild or Moderate COVID-19 . . . |
Ongoing |
18 May 2021 |
| | A Multinational, Randomized, Double-blind, Positive-controlled, Parallel Group Clinical Study to Compare the Efficacy and Safety of the JHL1101 in Combination with CHOP (J-CHOP) versus Rituximab in Co . . . |
Terminated |
17 Sep 2019 |